Publicacións en colaboración con investigadores/as de University Hospital Aachen (8)

2019

  1. Synthetic anti-lipopolysaccharide peptides (SALPs) as effective inhibitors of pathogen-associated molecular patterns (PAMPs)

    Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 111-129

2017

  1. Coupling killing to neutralization: Combined therapy with ceftriaxone/pep19-2.5 counteracts sepsis in rabbits

    Experimental and Molecular Medicine, Vol. 49, Núm. 6

2015

  1. Lipoproteins/peptides are sepsis-inducing toxins from bacteria that can be neutralized by synthetic anti-endotoxin peptides

    Scientific Reports, Vol. 5

  2. Therapeutical administration of peptide pep19-2.5 and ibuprofen reduces inflammation and prevents lethal sepsis

    PLoS ONE, Vol. 10, Núm. 7

2013

  1. Preclinical investigations reveal the broad-spectrum neutralizing activity of peptide pep19-2.5 on bacterial pathogenicity factors

    Antimicrobial Agents and Chemotherapy, Vol. 57, Núm. 3, pp. 1480-1487

2012

  1. Bacterial cell wall compounds as Promising targets of antimicrobial agents I. Antimicrobial peptides and lipopolyamines

    Current Drug Targets, Vol. 13, Núm. 9, pp. 1121-1130

  2. Bacterial cell wall compounds as promising targets of antimicrobial agents II. Immunological and clinical aspects

    Current Drug Targets, Vol. 13, Núm. 9, pp. 1131-1137

2010

  1. New antiseptic peptides to protect against endotoxin-mediated shock

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 9, pp. 3817-3824